DataSheet_1_Case Report: A New Gain-of-Function Mutation of STAT1 Identified in a Patient With Chronic Mucocutaneous Candidiasis and Rosacea-Like Demodicosis: An Emerging Association.docx
Heterozygous missense STAT1 mutations leading to a gain of function (GOF) are the most frequent genetic cause of chronic mucocutaneous candidiasis (CMC). We describe the case of a patient presenting a new GOF mutation of STAT1 with the clinical symptoms of CMC, recurrent pneumonia, and persistent central erythema with papulopustules with ocular involvement related to rosacea-like demodicosis.
MethodsGenetic analysis via targeted next-generation sequencing (NGS; NGS panel DIPAI v.1) exploring the 98 genes most frequently involved in primary immunodeficiencies, including STAT1, was performed to identify an underlying genetic defect.
ResultsNGS identified a novel variant of STAT1, c.884C>A (exon 10), p.T295Y, not previously described. This variant was found to be gain of function using an in vitro luciferase reporter assay. Rosacea-like demodicosis was confirmed by substantial Demodex proliferation observed via the microscopic examination of a cutaneous sample. A review of literature retrieved 20 other cases of STAT1 GOF mutations associated with early-onset rosacea-like demodicosis, most with ocular involvement.
ConclusionWe describe a new STAT1 GOF mutation associated with a phenotype of CMC and rosacea-like demodicosis. Rosacea-like demodicosis appears as a novel and important clinical phenotype among patients with STAT1 GOF mutation.
History
References
- https://doi.org//10.1007/s10875-019-00737-x
- https://doi.org//10.1007/s00439-020-02141-7
- https://doi.org//10.1056/NEJMoa1100102
- https://doi.org//10.1084/jem.20110958
- https://doi.org//10.1080/1744666X.2018.1531704
- https://doi.org//10.1007/s10875-015-0214-9
- https://doi.org//10.1007/s10875-020-00847-x
- https://doi.org//10.1182/blood-2015-11-679902
- https://doi.org//10.1111/jdv.14413
- https://doi.org//10.1111/pde.14011
- https://doi.org//10.1016/j.annder.2019.09.597
- https://doi.org//10.1111/jdv.16241
- https://doi.org//10.1007/s10875-020-00942-z
- https://doi.org//10.1111/cei.13636
- https://doi.org//10.7717/peerj.796
- https://doi.org//10.2340/00015555-3041
- https://doi.org//10.1001/archdermatol.2010.196
- https://doi.org//10.1111/jdv.14547
- https://doi.org//10.1016/j.det.2017.11.006
- https://doi.org//10.1016/j.jaad.2004.05.034
- https://doi.org//10.1016/s0190-9622(08)80268-x
- https://doi.org//10.1046/j.1365-2133.2001.03794.x
- https://doi.org//10.1016/j.jaad.2011.05.037
- https://doi.org//10.1258/ijsa.2008.008026
- https://doi.org//10.1159/000066430
- https://doi.org//10.2340/0001555573437
- https://doi.org//10.1016/j.nmni.2019.100525
- https://doi.org//10.1186/s13052-015-0125-7
- https://doi.org//10.3346/jkms.2011.26.9.1231
- https://doi.org//10.1111/jdv.14885
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity